| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT06517888 | Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | Vestibular Schwannoma | Recruiting | 2026-04-06 |
| Not specified | ||||
| NCT05572073 | Otoferlin Gene-mediated Hearing Loss Natural History Study | Sensorineural Hearing Loss, Bilateral | Recruiting | 2026-03-04 |
| NCT07503613 | Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy | Vestibular Schwannoma | Enrolling by Invitation | 2026-07-16 |
| NCT06696456 | Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy | Otoferlin Gene-mediated Hearing Loss | Enrolling by Invitation | 2026-04-06 |